Israel Englander Bio Path Holdings Inc Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$9.45 - $17.17 $94,585 - $171,854
-10,009 Closed
0 $0
Q2 2019

Aug 15, 2019
SELL
$12.52 - $20.81 $5.25 Million - $8.73 Million
-419,349 Reduced 97.67%
10,009 $134,000
Q2 2019

Aug 14, 2019
BUY
$12.52 - $20.81 $5.38 Million - $8.93 Million
429,358 New
429,358 $34.4 Million

About BIO-PATH HOLDINGS INC

BPTH Quotes by TradingView
  • Ticker BPTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,160,160
  • Market Cap $6.37M
  • Description
  • Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...
More about BPTH
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email